Warner Robert Keith's Form 4 filing
RxSight, Inc. (RXST) · filed Aug 5, 2021
- Accession no.
- 0000899243-21-031808
- Filed
- Aug 5, 2021
- Trade date
- Aug 3, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $700.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Warner Robert KeithCIK 0001874373 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 | Common Stock | AGrant or awardAcquired | +5,733 | $0.00F1 | $0 | 5,733 | Direct | |
| Aug 3, 2021 | Common Stock | AGrant or awardAcquired | +7,645 | $0.00F1 | $0 | 13,378 | Direct | |
| Aug 3, 2021 | Common Stock | PPurchaseAcquired | +43,750 | $16.00 | +$700,000 | 57,128 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
Referenced by the price of 2 transactions in Table I.